Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Low Back Pain - Overview
Low Back Pain - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Low Back Pain - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Low Back Pain - Companies Involved in Therapeutics Development
Low Back Pain - Drug Profiles
Low Back Pain - Dormant Projects
Low Back Pain - Discontinued Products
Low Back Pain - Product Development Milestones
Featured News & Press Releases
Jun 30, 2022: BioRestorative Therapies announces first patient enrolled for the company’s phase 2 clinical trial to treat chronic lumbar disc disease (cLDD)
Jun 22, 2022: BioRestorative Therapies announces clinical trial contract with second site for the company’s phase 2 clinical trial to treat chronic lumbar disc disease (cLDD)
Jun 13, 2022: BioRestorative Therapies announces clinical site initiation for the company’s phase 2 clinical trial to treat chronic lumbar disc disease (cLDD)
Apr 29, 2022: BioRestorative Therapies hosts principal investigator meeting for its BRTX-100 phase 2 clinical trial to treat chronic lumbar disc disease
Apr 18, 2022: BioRestorative Therapies announces selection of 10 clinical sites for its phase 2 clinical trial to treat chronic lumbar disc disease
Apr 04, 2022: BioRestorative Therapies announces cGMP Cell Manufacturing Facility Certification
Feb 16, 2022: Biorestorative Therapies announces notice of allowance on key patent for its BRTX-100 disc program
Feb 07, 2022: BioRestorative Therapies announces it has initiated its phase 2 clinical trial to treat chronic lumbar disc disease
Jan 04, 2022: BioRestorative Therapies awarded an STTR phase I grant to explore the therapeutic effects of PEG-Peptide hydrogel-encapsulated hypoxic bone marrow stem cells
Aug 20, 2021: Notification of application for manufacturing and marketing approval of the additiol indications of “low back pain, humeroscapular periarthritis, cervico-omo-brachial syndrome and tenosynovitis” for ZICTHORU Tapes (Transdermal, pain treatment NSAID patch, development code: HP-3150) in Japan
Aug 19, 2021: BioRestorative Therapies awarded one of top 10 spine device companies by MedTech Outlook
Jun 30, 2021: Mesoblast provides update on program for chronic low back pain due to degenerative disc disease
Feb 17, 2021: AnGes’ phase 1b results of NF-kappa B Oligo D Decoy administration in subjects with chronic discogenic low back pain support advancement into phase 2 clinical study
Feb 10, 2021: Mesoblast phase 3 trial shows that a single injection of Rexlemestrocel-L + Hyaluronic Acid carrier results in at least two years of pain reduction with opioid sparing activity in patients with chronic low back pain due to degenerative disc disease
Dec 07, 2020: Notification of the results of Phase clinical study of HP-3150 for “low back pain, humeroscapular periarthritis, cervico-omo-brachial syndrome and tenosynovitis” in Japan (transdermal, pain treatment NSAID patch)
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Low Back Pain, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Low Back Pain, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Companies, 2022 (Contd..1)
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Target, 2022 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Low Back Pain - Pipeline by Ache Laboratorios Farmaceuticos SA, 2022
Low Back Pain - Pipeline by Adynxx Inc, 2022
Low Back Pain - Pipeline by Allodynic Therapeutics LLC, 2022
Low Back Pain - Pipeline by Amplicore Inc, 2022
Low Back Pain - Pipeline by AnGes Inc, 2022
Low Back Pain - Pipeline by Axsome Therapeutics Inc, 2022
Low Back Pain - Pipeline by BioRestorative Therapies Inc, 2022
Low Back Pain - Pipeline by Bol Pharma, 2022
Low Back Pain - Pipeline by Camurus AB, 2022
Low Back Pain - Pipeline by Causeway Therapeutics Ltd, 2022
Low Back Pain - Pipeline by Creative Medical Technology Holdings Inc, 2022
Low Back Pain - Pipeline by Daewon Pharmaceutical Co Ltd, 2022
Low Back Pain - Pipeline by DongKoo Bio & Pharma Co Ltd, 2022
Low Back Pain - Pipeline by Eli Lilly and Co, 2022
Low Back Pain - Pipeline by Epione Therapeutics BV, 2022
Low Back Pain - Pipeline by Ethismos Research Inc, 2022
Low Back Pain - Pipeline by Evero Health Ltd, 2022
Low Back Pain - Pipeline by Gador SA, 2022
Low Back Pain - Pipeline by Hisamitsu Pharmaceutical Co Inc, 2022
Low Back Pain - Pipeline by Imbrium Therapeutics LP, 2022
Low Back Pain - Pipeline by Immune Pharmaceuticals Inc, 2022
Low Back Pain - Pipeline by Indaptus Therapeutics Inc, 2022
Low Back Pain - Pipeline by Laboratorios Silanes SA de CV, 2022
Low Back Pain - Pipeline by MD Biosciences GmbH, 2022
Low Back Pain - Pipeline by Mesoblast Ltd, 2022
Low Back Pain - Pipeline by Navipharm Co Ltd, 2022
Low Back Pain - Pipeline by Neumentum Inc, 2022
Low Back Pain - Pipeline by Pacira BioSciences Inc, 2022
Low Back Pain - Pipeline by Panacea Biotec Ltd, 2022
Low Back Pain - Pipeline by Persica Pharmaceuticals Ltd, 2022
Low Back Pain - Pipeline by Pfizer Inc, 2022
Low Back Pain - Pipeline by Rebus Holdings Inc, 2022
Low Back Pain - Pipeline by Scilex Holding Co, 2022
Low Back Pain - Pipeline by Sclnow Biotechnology Co Ltd, 2022
Low Back Pain - Pipeline by Shionogi & Co Ltd, 2022
Low Back Pain - Pipeline by Spine BioPharma LLC, 2022
Low Back Pain - Pipeline by Stayble Therapeutics AB, 2022
Low Back Pain - Pipeline by Sun Pharma Advanced Research Company Ltd, 2022
Low Back Pain - Pipeline by Tris Pharma Inc, 2022
Low Back Pain - Pipeline by Valenta Pharm, 2022
Low Back Pain - Pipeline by Vertanical GmbH, 2022
Low Back Pain - Pipeline by WEX Pharmaceuticals Inc, 2022
Low Back Pain - Pipeline by Xgene Pharmaceutical Inc, 2022
Low Back Pain - Dormant Projects, 2022
Low Back Pain - Dormant Projects, 2022 (Contd..1)
Low Back Pain - Discontinued Products, 2022